OR WAIT 15 SECS
Quality by Design: Where We Stand Now
On what aspects of Quality by Design is there now consensus within the industry and regulatory bodies, and what remains to be sorted out?
Join Laura Bush, Editor in Chief of BioPharm International and John Towns, Senior Director of Global CMC Regulatory Affairs at Eli Lilly, as they discuss the current state of QbD.
Related Content:Quality by Design